Regeneron Pharmaceuticals, Inc. Earnings

Regeneron Pharmaceuticals, Inc.’s revenue jumped 10.33% since last year same period to $3789.2Mn in the Q4 2024. On a quarterly growth basis, Regeneron Pharmaceuticals, Inc. has generated 1.84% jump in its revenue since last 3-months.

Regeneron Pharmaceuticals, Inc.’s net profit fell -20.86% since last year same period to $917.7Mn in the Q4 2024. On a quarterly growth basis, Regeneron Pharmaceuticals, Inc. has generated -31.55% fall in its net profits since last 3-months.

Regeneron Pharmaceuticals, Inc.’s net profit margin fell -28.27% since last year same period to 24.22% in the Q4 2024. On a quarterly growth basis, Regeneron Pharmaceuticals, Inc. has generated -32.78% fall in its net profit margins since last 3-months.

Regeneron Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at 11.38 - a -2.65% fall from last quarter’s estimates.

Regeneron Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at 11.38.

Regeneron Pharmaceuticals, Inc.’s earning per share (EPS) jumped 1.77% since last year same period to 12.07 in the Q4 2024. This indicates that the Regeneron Pharmaceuticals, Inc. has generated 1.77% annual rate of jump in its earning per share (EPS) in the last 4 quarters.